Hans Didier, Genton Laurence, Allaoua Samia, Pichard Claude, Slosman Daniel O
Division of Nuclear Medicine, Geneva University Hospital, Geneva, CH.
J Clin Densitom. 2003 Summer;6(2):163-72. doi: 10.1385/jcd:6:2:163.
As an emerging alternative to current radiation-based bone densitometry techniques, there is a growing interest in the use of quantitative ultrasound (QUS) measurements for the noninvasive assessment of fracture risk in the management of osteoporosis. However, there are also a multiplicity of technologically different QUS devices available on the market and, so far, no study has compared heel and radius QUS device for the discrimination of subjects with hip fractures. Our study evaluated the ability of three QUS devices (one calcaneal gel-coupled system, one calcaneal water-coupled system, and one radius system) to discriminate osteoporotic from controls subjects, using the same population. We also checked if the combination of two different skeletal sites (i.e., calcaneum and radius) improve the discriminatory ability of the QUS devices. Forty-five women aged 79.1+/-7.1 yr with hip fractures within the last 4 d were used as the hip-fracture group and compared to 40 healthy controls from 65-87 yr. In addition, 47 young controls, aged 20-40 yr, were used as reference population to express some of the results as T-scores. QUS measurements were performed with the Hologic Sahara, Ge-Lunar Achilles+, and Sunlight Omnisense devices according to the manufacturer's recommendations. Adjusted odds ratio results showed that a decrease in Omnisense SOS of 1 standard deviation (SD) was associated with a significant increase in fracture risk (OR adj.=2.83) comparable with Sahara BUA (OR adj.=2.42) and Achilles BUA (OR adj.=3.29). However, given the large overlap between the 95% intervals of each odds ratio, no significant difference was found between the devices. Similarly, comparison between the areas under ROC curves did not show any significant difference between all the parameters. Considering the parameters provided per default by each QUS device, the Sahara, Achilles, and Omnisense devices classified correctly 70, 67.5, and 62.5% of the subjects, respectively. Although the OR of the combination of radius and calcaneum is improved (3.62 to 4.74) compared with either one of the single skeletal site, the large confidence intervals do not allow to claim a significant difference. The three QUS technologies tested against hip fractures seem to show the same discriminatory ability. However, there is some differences in the definition of the diagnostic threshold underlying the nonusability of the World Health Organization (WHO) osteoporosis definition. Finally the combination of several site using two different devices is not clinically relevant. Potential interest could be seen in combining several sites using the same device, supposing that such device would measure differently active bone.
作为当前基于辐射的骨密度测量技术的一种新兴替代方法,定量超声(QUS)测量在骨质疏松症管理中用于骨折风险的无创评估越来越受到关注。然而,市场上也有多种技术不同的QUS设备,到目前为止,尚无研究比较足跟和桡骨QUS设备对髋部骨折患者的鉴别能力。我们的研究评估了三种QUS设备(一种足跟凝胶耦合系统、一种足跟水耦合系统和一种桡骨系统)使用同一人群鉴别骨质疏松症患者与对照者的能力。我们还检查了两个不同骨骼部位(即跟骨和桡骨)的组合是否能提高QUS设备的鉴别能力。将45名年龄79.1±7.1岁、在过去4天内发生髋部骨折的女性作为髋部骨折组,并与40名年龄在65 - 87岁的健康对照者进行比较。此外,47名年龄在20 - 40岁的年轻对照者作为参考人群,将部分结果表示为T值。根据制造商的建议,使用Hologic Sahara、Ge-Lunar Achilles+和Sunlight Omnisense设备进行QUS测量。调整后的优势比结果显示,Omnisense声速(SOS)降低1个标准差(SD)与骨折风险显著增加相关(调整后的OR = 2.83),与Sahara宽带超声衰减(BUA)(调整后的OR = 2.42)和Achilles BUA(调整后的OR = 3.29)相当。然而,鉴于每个优势比的95%区间有很大重叠,未发现各设备之间有显著差异。同样,ROC曲线下面积的比较也未显示所有参数之间有任何显著差异。考虑到每个QUS设备默认提供的参数,Sahara、Achilles和Omnisense设备分别正确分类了70%、67.5%和62.5%的受试者。尽管与单个骨骼部位之一相比,桡骨和跟骨组合的OR有所提高(从